Cargando…

Immune-regulating effects of exercise on cigarette smoke-induced inflammation

Long-term cigarette smoking (LTCS) represents an important risk factor for cardiac infarction and stroke and the central risk factor for the development of a bronchial carcinoma, smoking-associated interstitial lung fibrosis, and chronic obstructive pulmonary disease. The pathophysiologic developmen...

Descripción completa

Detalles Bibliográficos
Autores principales: Madani, Ashkan, Alack, Katharina, Richter, Manuel Jonas, Krüger, Karsten
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5923223/
https://www.ncbi.nlm.nih.gov/pubmed/29731655
http://dx.doi.org/10.2147/JIR.S141149
_version_ 1783318290219663360
author Madani, Ashkan
Alack, Katharina
Richter, Manuel Jonas
Krüger, Karsten
author_facet Madani, Ashkan
Alack, Katharina
Richter, Manuel Jonas
Krüger, Karsten
author_sort Madani, Ashkan
collection PubMed
description Long-term cigarette smoking (LTCS) represents an important risk factor for cardiac infarction and stroke and the central risk factor for the development of a bronchial carcinoma, smoking-associated interstitial lung fibrosis, and chronic obstructive pulmonary disease. The pathophysiologic development of these diseases is suggested to be promoted by chronic and progressive inflammation. Cigarette smoking induces repetitive inflammatory insults followed by a chronic and progressive activation of the immune system. In the pulmonary system of cigarette smokers, oxidative stress, cellular damage, and a chronic activation of pattern recognition receptors are described which are followed by the translocation of the NF-kB, the release of pro-inflammatory cytokines, chemokines, matrix metalloproteases, and damage-associated molecular patterns. In parallel, smoke pollutants cross directly through the alveolus–capillary interface and spread through the systemic bloodstream targeting different organs. Consequently, LTCS induces a systemic low-grade inflammation and increased oxidative stress in the vascular system. In blood, these processes promote an increased coagulation and endothelial dysfunction. In muscle tissue, inflammatory processes activate catabolic signaling pathways followed by muscle wasting and sarcopenia. In brain, several characteristics of neuroinflammation were described. Regular exercise training has been shown to be an effective nonpharmacological treatment strategy in smoke-induced pulmonary diseases. It is well established that exercise training exerts immune-regulating effects by activating anti-inflammatory signaling pathways. In this regard, the release of myokines from contracting skeletal muscle, the elevations of cortisol and adrenalin, the reduced expression of Toll-like receptors, and the increased mobilization of immune-regulating leukocyte subtypes might be of vital importance. Exercise training also increases the local and systemic antioxidative capacity and several compensatory mechanisms in tissues such as an increased anabolic signaling in muscle or an increased compliance of the vascular system. Accordingly, regular exercise training seems to protect long-term smokers against some important negative local and systemic consequences of smoking. Data suggest that it seems to be important to start exercise training as early as possible.
format Online
Article
Text
id pubmed-5923223
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Dove Medical Press
record_format MEDLINE/PubMed
spelling pubmed-59232232018-05-04 Immune-regulating effects of exercise on cigarette smoke-induced inflammation Madani, Ashkan Alack, Katharina Richter, Manuel Jonas Krüger, Karsten J Inflamm Res Review Long-term cigarette smoking (LTCS) represents an important risk factor for cardiac infarction and stroke and the central risk factor for the development of a bronchial carcinoma, smoking-associated interstitial lung fibrosis, and chronic obstructive pulmonary disease. The pathophysiologic development of these diseases is suggested to be promoted by chronic and progressive inflammation. Cigarette smoking induces repetitive inflammatory insults followed by a chronic and progressive activation of the immune system. In the pulmonary system of cigarette smokers, oxidative stress, cellular damage, and a chronic activation of pattern recognition receptors are described which are followed by the translocation of the NF-kB, the release of pro-inflammatory cytokines, chemokines, matrix metalloproteases, and damage-associated molecular patterns. In parallel, smoke pollutants cross directly through the alveolus–capillary interface and spread through the systemic bloodstream targeting different organs. Consequently, LTCS induces a systemic low-grade inflammation and increased oxidative stress in the vascular system. In blood, these processes promote an increased coagulation and endothelial dysfunction. In muscle tissue, inflammatory processes activate catabolic signaling pathways followed by muscle wasting and sarcopenia. In brain, several characteristics of neuroinflammation were described. Regular exercise training has been shown to be an effective nonpharmacological treatment strategy in smoke-induced pulmonary diseases. It is well established that exercise training exerts immune-regulating effects by activating anti-inflammatory signaling pathways. In this regard, the release of myokines from contracting skeletal muscle, the elevations of cortisol and adrenalin, the reduced expression of Toll-like receptors, and the increased mobilization of immune-regulating leukocyte subtypes might be of vital importance. Exercise training also increases the local and systemic antioxidative capacity and several compensatory mechanisms in tissues such as an increased anabolic signaling in muscle or an increased compliance of the vascular system. Accordingly, regular exercise training seems to protect long-term smokers against some important negative local and systemic consequences of smoking. Data suggest that it seems to be important to start exercise training as early as possible. Dove Medical Press 2018-04-24 /pmc/articles/PMC5923223/ /pubmed/29731655 http://dx.doi.org/10.2147/JIR.S141149 Text en © 2018 Madani et al. This work is published and licensed by Dove Medical Press Limited The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed.
spellingShingle Review
Madani, Ashkan
Alack, Katharina
Richter, Manuel Jonas
Krüger, Karsten
Immune-regulating effects of exercise on cigarette smoke-induced inflammation
title Immune-regulating effects of exercise on cigarette smoke-induced inflammation
title_full Immune-regulating effects of exercise on cigarette smoke-induced inflammation
title_fullStr Immune-regulating effects of exercise on cigarette smoke-induced inflammation
title_full_unstemmed Immune-regulating effects of exercise on cigarette smoke-induced inflammation
title_short Immune-regulating effects of exercise on cigarette smoke-induced inflammation
title_sort immune-regulating effects of exercise on cigarette smoke-induced inflammation
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5923223/
https://www.ncbi.nlm.nih.gov/pubmed/29731655
http://dx.doi.org/10.2147/JIR.S141149
work_keys_str_mv AT madaniashkan immuneregulatingeffectsofexerciseoncigarettesmokeinducedinflammation
AT alackkatharina immuneregulatingeffectsofexerciseoncigarettesmokeinducedinflammation
AT richtermanueljonas immuneregulatingeffectsofexerciseoncigarettesmokeinducedinflammation
AT krugerkarsten immuneregulatingeffectsofexerciseoncigarettesmokeinducedinflammation